undamentalytics Newsletter

Barrow Robert: insider trades

Chief executive at Definium Therapeutics, Inc. No open-market purchases and 12 sales not made under a pre-set plan, reported from May 26, 2022 to December 26, 2023.

What happened after Barrow Robert’s sales?

After their sales, the shares moved −79.9% against the index over 12 months on average (a negative figure means selling was the right call); 100% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Barrow Robert: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 1 −81.1% −81.1% 100% 1 — — Not enough years
Sales, 12 months after the report 1 −79.9% −79.9% 100% 1 — — Not enough years
Sales, 12 months after the trade 1 −81.0% −81.0% 100% 1 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Definium Therapeutics, Inc. DFTX Chief Executive Officer012May 26, 2022December 26, 2023

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
December 26, 2023December 26, 2023 DFTX Sale $48,050 not yetnot yetnot yet
September 25, 2023September 25, 2023 DFTX Sale $48,274 not yetnot yetnot yet
June 27, 2023June 27, 2023 DFTX Sale $49,620 not yetnot yetnot yet
March 2, 2023March 1, 2023 DFTX Sale $29,038 not yetnot yetnot yet
December 22, 2022December 21, 2022 DFTX Sale $10,386 not yetnot yetnot yet
September 1, 2022August 31, 2022 DFTX Sale $14,331 −81.1%−79.9%−81.0%
August 17, 2022August 16, 2022 DFTX Sale $13,838 not yetnot yetnot yet
July 26, 2022July 25, 2022 DFTX Sale $12,890 not yetnot yetnot yet
July 18, 2022July 18, 2022 DFTX Sale $13,572 not yetnot yetnot yet
June 28, 2022June 27, 2022 DFTX Sale $25,733 not yetnot yetnot yet
June 21, 2022June 16, 2022 DFTX Sale $14,892 not yetnot yetnot yet
May 26, 2022May 25, 2022 DFTX Sale $14,180 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Barrow Robert traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.